Cardiac Assist Devices Market by Type (Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pump (IABP), Total Artificial Hearts (TAH)), Modality (Implantable, Transcutaneous), End User - Global Forecast 2024-2030

Cardiac Assist Devices Market by Type (Extracorporeal Membrane Oxygenation, Intra-Aortic Balloon Pump (IABP), Total Artificial Hearts (TAH)), Modality (Implantable, Transcutaneous), End User - Global Forecast 2024-2030

The Cardiac Assist Devices Market size was estimated at USD 1.46 billion in 2023 and expected to reach USD 1.55 billion in 2024, at a CAGR 6.51% to reach USD 2.28 billion by 2030.

Cardiac assist devices (CADs) are sophisticated medical devices designed to support and augment the pumping function of the heart in patients with heart failure or other heart-related conditions. They play a critical role in managing end-stage heart failure patients, providing a bridge to heart transplantation, serving as a destination therapy, or supporting the heart during or after surgeries. The increase in the prevalence of cardiovascular diseases worldwide, attributable to sedentary lifestyles, aging populations, and the rise in hypertension and diabetes, has surged the need for cardiac assist devices. Additionally, the expanding global awareness about the available advanced cardiac support options and the growing healthcare expenditures in emerging economies are also contributing to the market growth. Moreover, the risks and complications associated with device implantation, such as infections, bleeding, and device malfunction, pose significant challenges to the growth of the cardiac assist devices market. Furthermore, technological advancements that improve the efficacy and safety of cardiac assist devices that broaden their acceptance among healthcare providers and patients are expected to create opportunities for market growth.

Regional Insights

The Americas represents a highly developing landscape for the global market for cardiac assist devices due to the high prevalence of cardiovascular diseases, robust healthcare infrastructure, and significant investments in research and development. The region benefits from the presence of key market players that focus on innovation and launching technologically advanced products. Medical device regulation policies in the US are also conducive to the rapid adoption of new technologies. Moreover, the increasing aging population and favorable reimbursement scenarios further stimulate market growth. The APAC region is witnessing growth in the cardiac assist devices market, attributed mainly to the rising incidence of cardiac diseases, improving healthcare infrastructure, and increasing healthcare expenditure. Countries including China and India, with their vast population bases and growing middle-class, present significant opportunities for market expansion. The region also benefits from government initiatives aimed at improving healthcare access. The EMEA region showcases a strong landscape for cardiac assist devices due to its advanced healthcare system, high healthcare expenditure, and increasing prevalence of cardiovascular diseases. Countries such as Germany, the UK, and France are at the forefront, driven by favorable healthcare policies, high awareness levels, and well-established healthcare infrastructure. The Middle East is rapidly growing due to increasing healthcare investments and a growing focus on healthcare modernization.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Cardiac Assist Devices Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers

• Increasing prevalence of cardiovascular diseases worldwide
• Growing adoption of minimally invasive devices
• Rising awareness for preventative healthcare and early diagnosis

Market Restraints

• Risks and complications associated with cardiac assist device implantation

Market Opportunities

• Growing technological advancements in cardiac assist devices
• High inclination towards portable cardiac assist devices with emerging trend of remote healthcare monitoring

Market Challenges

• Technical limitations with the usage of cardiac assist devices

Market Segmentation Analysis

• Type: Growing usage of intra-aortic balloon pumps to increase myocardial oxygen perfusion
• End User: High need for cardiac assist devices across hospitals that can handle a wide spectrum of cardiac conditions

Market Disruption Analysis

• Porter’s Five Forces Analysis
• Value Chain & Critical Path Analysis
• Pricing Analysis
• Technology Analysis
• Patent Analysis
• Trade Analysis
• Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Cardiac Assist Devices Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Cardiac Assist Devices Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Supira Medical's Next Generation Percutaneous Ventricular Assist Device (pVAD) System to be Highlighted in a Live Case and Multiple Sessions at the Upcoming TCT 2023 Conference

Supira Medical, Inc. launched a percutaneous ventricular assist device (pVAD), including an anticipated live case demonstration. This inclusion underscores the system's pioneering approach, characterized by its minimal invasiveness and superior continuous flow capabilities, which are poised to revolutionize hemodynamic support for both practitioners and patients alike.

Abbott Receives FDA Approval for World's First Dual Chamber Leadless Pacemaker

Abbott has received approval from the U.S. Food and Drug Administration (FDA) for its groundbreaking AVEIR DR leadless pacemaker system, marking a significant milestone in cardiac care technology. This innovative system, which is the first of its kind to offer dual chamber leadless pacing, is designed to address the needs of patients experiencing abnormal or slow heart rhythms by providing pacing to both the right atrium and right ventricle. This approval is poised to benefit millions of Americans, as over 80% of pacemaker users require dual-chamber pacing. The AVEIR DR system represents a leap forward in medical technology, providing an expanded range of leadless pacing options and enhancing the treatment capabilities for individuals with heart rhythm disorders.

UltraLinQ to Launch New Cardiac Monitoring Product at Arab Health

Ultralinq announced the launch of ITS latest product in cardiac monitoring at Arab Health. This innovative solution offers advanced and comprehensive Holter ECG monitoring for improved patient care. The state-of-the-art Holter ECG monitor can record and store up to 14 days of high-quality ECG data. Its user-friendly design simplifies the patient experience and reduces the time spent during clinic appointments.

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Cardiac Assist Devices Market. This critical assessment involves a thorough analysis of the organization’s resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Assist Devices Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AlivCor Inc., Bardy Diagnostics, Inc., Berlin Heart GmbH, BiVACOR Inc., Boston Scientific Corporation, Cardiac Insight, Inc., Cardiobridge GmbH, CorInnova, Inc., CorWave SA, GE HealthCare Technologies Inc., Getinge AB, Hill-Rom Holdings, Inc., Jarvik Heart Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, OSI Systems, Inc., Supira Medical, Teleflex Incorporated, Terumo Corporation, and Xenios AG.

Market Segmentation & Coverage

This research report categorizes the Cardiac Assist Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Type
• Extracorporeal Membrane Oxygenation
• Intra-Aortic Balloon Pump (IABP)
• Total Artificial Hearts (TAH)
• Ventricular Assist Devices (VADs)
• Left Ventricular Assist Devices (LVADs)
• Right Ventricular Assist Devices (RVADs)
• Modality
• Implantable
• Transcutaneous
• End User
• Ambulatory Surgical Centers
• Hospitals & Specialty Clinics

Region

• Americas
• Argentina
• Brazil
• Canada
• Mexico
• United States
• California
• Florida
• Illinois
• New York
• Ohio
• Pennsylvania
• Texas
• Asia-Pacific
• Australia
• China
• India
• Indonesia
• Japan
• Malaysia
• Philippines
• Singapore
• South Korea
• Taiwan
• Thailand
• Vietnam
• Europe, Middle East & Africa
• Denmark
• Egypt
• Finland
• France
• Germany
• Israel
• Italy
• Netherlands
• Nigeria
• Norway
• Poland
• Qatar
• Russia
• Saudi Arabia
• South Africa
• Spain
• Sweden
• Switzerland
• Turkey
• United Arab Emirates
• United Kingdom

Please Note: PDF & Excel + Online Access - 1 Year